↓ Skip to main content

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype

Overview of attention for article published in BMC Cancer, October 2010
Altmetric Badge

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
23 Mendeley